Prognostic Value of Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: A Long-term Follow-up Study

Domschke, Christoph; Diel, Ingo; Englert, Stefan; Kalteisen, Silvia; Mayer, Luisa; Rom, Joachim; Heil, Joerg; Sohn, Christof; Schuetz, Florian
June 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jun2013, Vol. 20 Issue 6, p1865
Academic Journal
No abstract available.


Related Articles

  • Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in... Diel, Ingo J.; Kaufmann, Manfred // JNCI: Journal of the National Cancer Institute;11/20/96, Vol. 88 Issue 22, p1652 

    Compares the value of tumor cell detection in bone marrow with axillary lymph node dissection in the prognosis of primary breast cancer after surgery. Profile of the patients; Prognostic indicators; Recommendations of the study.

  • Circulating Tumor Cells as Markers for Cancer Risk Assessment and Treatment Monitoring. Kasimir-Bauer, Sabine // Molecular Diagnosis & Therapy;Aug2009, Vol. 13 Issue 4, p209 

    Carcinomas of epithelial origin represent the majority of malignancies in Europe. A substantial number of patients develop recurrent carcinoma, which is explained by tumor-cell dissemination into distant organs, preferentially bone marrow, which often occurs prior to surgery. In contrast to...

  • Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: A prospective observational study. Solá, Montserrat; Margelí, Mireia; Castellá, Eva; Julian, Juan F.; Rull, Miquel; Gubern, Josep M.; Mariscal, Antonio; Barnadas, Agustí; Fraile, Manuel // BMC Cancer;2011, Vol. 11 Issue 1, p252 

    Background: The aim of this study was to investigate the incidence and prognostic value of disseminated tumor cells in bone marrow of breast carcinoma patients with early disease, and to analyze this finding in relation to lymph node involvement, determined by sentinel lymph node (SLN) biopsy...

  • Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients. Sven Becker; Erich Solomayer; Graziella Becker-Pergola; Diethelm Wallwiener; Tanja Fehm // Breast Cancer Research & Treatment;Dec2007, Vol. 106 Issue 2, p239 

    Abstract Introduction  The presence of disseminated tumor cells in the bone marrow of breast cancer patients has proven to be an independent prognostic factor. The aim of this study was to investigate the status of tumor cell dissemination after primary systemic therapy in...

  • Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues. Vincent-Salomon, A.; Bidard, F. C.; Pierga, J. Y. // Journal of Clinical Pathology;May2008, Vol. 61 Issue 5, p570 

    Immunocytochemical detection of disseminated tumour cells in the bone marrow of patients with primary breast cancer at surgery has been shown to be an independent prognostic factor in single institutional studies and in a large pooled analysis. However, bone marrow sampling and assessment of...

  • Breast Cancer (Systemic and Supportive Therapy).  // Journal of Cancer Research & Clinical Oncology;2004 Supplement 1, Vol. 130, pS43 

    Presents abstracts of articles about systemic and supportive therapy for breast cancer. Psychosocial distress screening of ambulatory breast cancer patients during chemotherapy; Systemic chemotherapy for metastatic breast cancer; Fate of disseminated tumor cells in bone marrow of primary breast...

  • Biology - Disease.  // Current Medical Literature: Breast Cancer;2007, Vol. 19 Issue 2, p40 

    The article discusses several studies related to breast cancer. In a study by S. Schulze and colleagues, the prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients is investigated. A study by H. Li et al showed that...

  • Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study. Falck, Anna-Karin; Bendahl, Pär-Ola; Ingvar, Christian; Isola, Jorma; Jönsson, Per-Ebbe; Lindblom, Pia; Lövgren, Kristina; Rennstam, Karin; Fernö, Mårten; Rydén, Lisa // BMC Cancer;2012, Vol. 12 Issue 1, p403 

    Background: Disseminated tumour cells (DTCs) in the bone marrow of patients with breast cancer have been identified as an independent predictor of poor prognosis in patients with non-metastatic disease. This prospective study aimed to evaluate the presence and prognostic value of DTCs in the...

  • Detection of disseminated tumor cells in aspirative drains after neck dissection. Mastronicola, R.; Berteau, C.; Tu, Q.; Cortese, S.; Guillet, J.; Phulpin, B.; Gangloff, P.; Bezdetnaya, L.; Merlin, J-L.; Faure, G.; Dolivet, G. // European Archives of Oto-Rhino-Laryngology;Feb2016, Vol. 273 Issue 2, p465 

    The dissemination of individual tumor cells is a common phenomenon in solid cancers. Detection of tumor cells in bone marrow disseminated tumor cells (DTC) and in peripheral blood circulating tumor cells (CTC) in nonmetastatic situation is of high prognostic significance. Compared to breast,...

  • Prognostic Significance of Circulating Breast Cancer Cells in Patients with Known Metastatic Disease. Ershler, William B. // Clinical Oncology Alert;Apr2008, Vol. 24 Issue 4, p29 

    IT HAS BEEN PREVIOUSLY REPORTED THAT THE DETECTION of disseminated tumor cells in the bone marrow is an independent prognostic factor for patients with early stage breast cancer. In a pooled analysis of bone marrow, breast cancer cells were detected in 31% of those with stage I through III...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics